Juenger v. Deaconess Health System, Inc.

CourtDistrict Court, S.D. Illinois
DecidedSeptember 30, 2025
Docket3:24-cv-02332
StatusUnknown

This text of Juenger v. Deaconess Health System, Inc. (Juenger v. Deaconess Health System, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Juenger v. Deaconess Health System, Inc., (S.D. Ill. 2025).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF ILLINOIS

JOEL JUENGER, Individually and on behalf of all others similarly situated,

Plaintiff,

v. Case No. 3:24-CV-2332-NJR

DEACONESS HEALTH SYSTEM, INC., DEACONESS ILLINOIS RED BUD REGIONAL HOSPITAL, INC., and RED BUD ILLINOIS HOSPITAL COMPANY, LLC,

Defendants.

MEMORANDUM AND ORDER

ROSENSTENGEL, Chief Judge: In this case, which is nearly identical to another case pending before the undersigned,1 Plaintiff Joel Juenger alleges that Defendants Deaconess Health System, Inc. and Deaconess Illinois Red Bud Regional Hospital, Inc. (“the Deaconess Defendants”) and Red Bud Illinois Hospital Company, LLC (“RBR”) (collectively, “Defendants”), violated his privacy rights. Specifically, Juenger claims that RBR used digital analytical tools on its website, which “collected and transmitted patients’ Private Information to Facebook and Google, possibly other third parties, without patients’ knowledge or authorization.” (Doc. 1). Now before the Court are Defendants’ Motions to Dismiss for Failure to State a Claim under Rule 12(b)(6) of the Federal Rules of Civil Procedure. (Docs. 19, 24). As with

1 Doe v. Deaconess Illinois Union County Hospital, Inc., Case No. 3:24-cv-02284-NJR. the aforementioned companion case, Doe v. Deaconess Illinois Union County Hospital, Inc., Case No. 3:24-cv-02284-NJR, the Court grants in part and denies in part Defendants’

motions to dismiss. BACKGROUND The following facts are taken from Juenger’s complaint and are accepted as true for the purposes of Defendants’ Motions to Dismiss. Wagner v. Teva Pharms. USA, Inc., 804 F.3d 355, 358 (7th Cir. 2016). RBR, located in Red Bud, Illinois, serves the Southern Illinois region with

impatient and outpatient care; emergency, medical and surgical services; rehabilitation; and diagnostic imaging. (Doc. 1 at ¶ 9). It serves as “critical access hospital” with 25 beds and a medical staff of 150. (Id. at ¶ 40). Juenger alleges that RBR’s website, https://redbudregional.com/, is equipped with “code-based tracking devices known as “trackers” or “tracking technologies” that

collected and transmitted patients’ Private Information to Facebook and Google, possibly other third parties, without patients’ knowledge or authorization. (Id. ¶ 10). According to Juenger, Defendants encourage patients to use the RBR website, along with their various web-based tools and services (collectively, the “Online Platforms”), to learn about RBR, to find medical providers, to find and research medical

services, to access a patient portal, to pay bills, to access medical records, and more. (Id. at ¶ 11). He further claims that when he and other putative class members visited RBR’s Online Platforms in relation to their past, present, and future healthcare needs and/or to transmit a payment for health care, they thought they were communicating exclusively with “their trusted healthcare provider.” (Id. at ¶ 12). Unbeknownst to them, RBR embedded pixels from Facebook and Google, and possibly others, into its Website and

Online Platforms, forcing Juenger and the putative class members to transmit intimate details about their medical treatment to third parties without their consent. (Id. at ¶ 13). The complaint explains a “tracker” as follows: A tracker . . . is a snippet of code embedded into a website that tracks information about its visitors and their website interactions. When a person visits a website with an [sic] tracker, it tracks “events” (i.e., user interactions with the site), such as pages viewed, buttons clicked, and information submitted. Then, the tracker transmits the event information back to the website server and to third parties, where it can be combined with other data and used for marketing. (Id. ¶ 14).

One example of such a tracker is Meta’s “Pixel,” which tracks a visitor’s activity on a website, including their search terms, button clicks, and form submissions. (Id. ¶ 15). The Meta Pixel also allows the visitor’s website interactions to be linked to their Facebook ID, so that otherwise anonymized data can be matched to a specific individual. (Id.). Juenger alleges that “[b]y installing the Meta Pixel on its Website, Defendants effectively planted a bug on Plaintiff’s and Class Members’ web browsers and compelled them to disclose Private Information and confidential communications to Facebook, without their authorization or knowledge.” (Id. ¶ 16). Defendants allegedly “utilized data from these trackers to market their services and bolster their profits.” (Id. ¶ 20). Facebook, in turn, “utilizes data from the Meta Pixel . . . to build data profiles for the purpose of creating targeted online advertisements and enhanced marketing services, which it sells to additional third parties for profit.” (Id.). Information that RBR’s Meta Pixel sent to Facebook included Juenger and the putative class’s browsing activities, including the pages they viewed and the buttons they clicked; information concerning their status as patients such as patient portal activities;

information concerning their medical concerns such as the providers they searched for and viewed and the medical services they viewed; and identifying information, such as IP addresses and identifying cookies. (Id. at ¶ 21). Juenger alleges this information allows third parties like Facebook to learn of a patient’s health conditions, which Facebook then sells to third-party marketers. (Id. at ¶ 22). The information could also allow others to infer that a specific patient was being treated for a specific medical condition like cancer,

pregnancy, or HIV. (Id.). Defendants allegedly also installed other trackers like Google Analytics, Google Tag Manager, and DoubleClick Ads, which operate similarly to the Meta Pixel and transmit personally identifiable information (PII) and/or personal health information (“PHI”) to unauthorized third parties. (Id. ¶ 23).

Juenger was a patient at RBR for a head injury beginning in May 2023. (Id. at ¶ 87). He used the RBR website multiple times to search for doctors specializing in post- concussion treatment, to pay his medical bills, and to use the patient portal. (Id. at ¶ 88). He later began receiving targeted advertisements on Facebook for RBR doctors, related medical services and testing, and vaccinations. (Id. at ¶ 92). On information and belief,

through its use of the Meta Pixel and other tracking technologies, Juenger claims RBR disclosed to Facebook the pages and content he viewed; his seeking of medical treatment; his status as a patient; his patient portal activity; the medical providers and specialties he searched for; the search results he clicked on; the medical services he viewed; and his identity via his IP address and/or his Facebook ID. (Id. at ¶ 97). Juenger filed this putative class action in October 2024. (Doc. 1) He advances the

following claims on behalf of himself and others whose PHI and PII were allegedly compromised: (i) negligence; (ii) negligence per se; (iii) invasion of privacy—intrusion upon seclusion; (iv) breach of implied contract; (v) unjust enrichment; (vi) breach of implied duty of confidentiality; (vii) violation of Illinois Consumer Fraud and Deceptive Business Practices Act (“ICFA”); (viii) violation of the Illinois Eavesdropping Statute; (ix) violation of the Electronic Communications Privacy Act (“ECPA” or “Wiretap Act”);

(x) violation of the ECPA (“unauthorized divulgence”); (xi) violation of the Stored Communications Act (“SCA”); and (xii) violation of the Computer Fraud and Abuse Act (“CFAA”). (Doc. 1). Defendants filed motions to dismiss the case pursuant to Federal Rule of Civil Procedure

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Swanson v. Citibank, N.A.
614 F.3d 400 (Seventh Circuit, 2010)
Caro v. Weintraub
618 F.3d 94 (Second Circuit, 2010)
Cleary v. Philip Morris Inc.
656 F.3d 511 (Seventh Circuit, 2011)
Brewster McCauley v. City of Chicag
671 F.3d 611 (Seventh Circuit, 2011)
Dan Richards v. Michael Mitcheff
696 F.3d 635 (Seventh Circuit, 2012)
Michael Burke v. 401 N. Wabash Venture, L.L.C.
714 F.3d 501 (Seventh Circuit, 2013)
Alliance Acceptance Co. v. Yale Insurance Agency, Inc.
648 N.E.2d 971 (Appellate Court of Illinois, 1995)
Charles Hester Enterprises, Inc. v. Illinois Founders Insurance
484 N.E.2d 349 (Appellate Court of Illinois, 1985)
Imperial Apparel, Ltd. v. Cosmo's Designer Direct, Inc.
882 N.E.2d 1011 (Illinois Supreme Court, 2008)
In re the Estate of Powell
2014 IL 115997 (Illinois Supreme Court, 2014)
Patrick Camasta v. Jos. A. Bank Clothiers, Inc.
761 F.3d 732 (Seventh Circuit, 2014)
Keith Horist v. Sudler & Company
941 F.3d 274 (Seventh Circuit, 2019)
Clarisha Benson v. Fannie May Confections Brands
944 F.3d 639 (Seventh Circuit, 2019)
Van Buren v. United States
593 U.S. 374 (Supreme Court, 2021)
Christopher Bilek v. Federal Insurance Company
8 F.4th 581 (Seventh Circuit, 2021)

Cite This Page — Counsel Stack

Bluebook (online)
Juenger v. Deaconess Health System, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/juenger-v-deaconess-health-system-inc-ilsd-2025.